You are here

Article Text

Article menu
Download PDFPDF
Treatment
Review: anticholinergic drugs improve symptoms but increase dry mouth in adults with overactive bladder syndrome

https://doi.org/10.1136/ebn.6.2.49

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hay-Smith J, Herbison P, Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.Cochrane Database Syst Rev2002;(3):CD003781 (latest version May 29 2002).

    QUESTION: What are the effects of anticholinergic drugs in adults with overactive bladder syndrome?

    Data sources

    Studies were identified by searching the Cochrane Incontinence Group trials register (to January 2002) and reference lists of relevant papers.

    Study selection

    Randomised or quasi-randomised controlled trials in adults with symptomatic diagnosis of overactive bladder syndrome, urodynamic diagnosis of detrusor overactivity, or both, that compared an anticholinergic drug (given to decrease symptoms of overactive bladder) with placebo or no treatment. Studies of darifenacin, emepronium bromide or carrageenate, dicyclomine chloride, oxybutynin chloride, propiverine, propantheline bromide, tolterodine, and trospium chloride were included. Studies of terodiline or drugs with …

    View Full Text

    Footnotes

    • For correspondence: Jean Hay-Smith, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.jean.hay-smith{at}otago.ac.nz

    • Source of funding: Health Research Council of Aotearoa New Zealand.